1-4 of 4
Wojciech Homenda
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Safety and efficacy of rilzabrutinib vs placebo in adults with immune thrombocytopenia: the phase 3 LUNA3 study

David J Kuter, Waleed Ghanima, Nichola Cooper, Howard Allen Liebman, Lei Zhang, Yu Hu, Yoshitaka Miyakawa, Wojciech Homenda, Luisa Elena Elena Morales Galindo, MD, Ana Lisa Basquiera, Chuen Wen Tan, Guray Saydam, Prof Dr, Marie Luise Hütter-Krönke, Chatree Chai-Adisaksopha, David Gomez-Almaguer, Huy Tran, Ho-Jin Shin, Ademar Dantas da Cunha Junior, Zsolt Lazar, Cristina Pascual-Izquierdo, Ilya Kirgner, Elisa Lucchini, Ganna Kuzmina, Michael Fillitz, Sylvain Audia, Minakshi Taparia, Matias Cordoba, Remco Diab, Mengjie Yao, Imene Gouia, Dr., Michelle Lee, Ahmed Abd Almalik Daak
Journal: Blood
Blood blood.2024027336.
https://doi.org/10.1182/blood.2024027336
Published: 2025
Includes: Supplemental data
Journal Articles

Disease-Modifying Activity of Navtemadlin Correlates with Clinical Responses in a Randomized, Multicenter, Global Phase 3 Study (BOREAS) in JAK-Inhibitor Relapsed/Refractory Myelofibrosis

John O. Mascarenhas, Prithviraj Bose, Hsin-An Hou, Wojciech Homenda, David Ross, Sanjay R Mohan, Jean-Jacques Kiladjian, Haifa Kathrin Al-Ali, Andrew Perkins, Yulia Khalina, Tracy Clevenger, Zhuying Huang, Jesse McGreivy, Wayne Rothbaum, Srdan Verstovsek, Alessandro M. Vannucchi
Journal: Blood
Blood (2024) 144 (Supplement 1): 483.
https://doi.org/10.1182/blood-2024-205937
Published: 2024
Journal Articles

Long-Term Evaluation of Efficacy and Safety of Ofatumumab Added to Fludarabine & Cyclophosphamide in Subjects with Relapsed Chronic Lymphocytic Leukemia: Final Analysis of Complement 2 Trial

Sebastian Grosicki, MD PhD, Ewa Lech-Maranda, MD PhD, K Govind Babu, MD DM, Justyna Rybka, MD PhD, Elena Litvinskaya, PhD, Javier Loscertales, MD, Irina Kryachok, Prof., PhD, Janusz Kłoczko, Prof., PhD, Grygoriy Rekhtman, MD, Wojciech Homenda, MD PhD, Jerzy Blonski, MD PhD, Tommaso Stefanelli, Ghislaine Vincent, Hiya Banerjee, Tadeusz Robak, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3151.
https://doi.org/10.1182/blood-2018-99-112139
Published: 2018
Journal Articles

Health-Related Quality of Life and Patient-Reported Outcomes in Patients Receiving Ofatumumab in Combination with Fludarabine and Cyclophosphamide (FC) Versus FC Alone in the Complement 2 Trial

Tadeusz Robak, MD Professor, Krzysztof Warzocha, MD PhD, K Govind Babu, Yaroslav Kulyaba, Kazimierz Kuliczkowski, Kudrat Abdulkadyrov, MD PhD, Javier Loscertales, Iryna Kryachok, Janusz Kloczko, Grygoriy Rekhtman, Wojciech Homenda, Jerzy Blonski, Astrid McKeown, PhD, Chai-Ni Chang, Stephanie C Manson, Steen Lisby, Ira V. Gupta, MD, Sebastian Grosicki, MD PhD
Journal: Blood
Blood (2015) 126 (23): 5288.
https://doi.org/10.1182/blood.V126.23.5288.5288
Published: 2015